SEPTIC ARTHRITIS/SEPTIC PHYSITIS
SEPTIC ARTHRITIS/SEPTIC PHYSITIS
Presented by: Erika Little, DVM, MBA, MS, Dipl. ACVS
RELEVANT READING MATERIAL
Chapter 86, Synovial and Osseous Infection
Pages 1458 - 1470, Auer & Stick Equine Surgery, Fifth Edition
OVERVIEW
Causes
Pathogenesis
Foals
Adults
Consequences
Treatments
OVERVIEW - CAUSES
Naturally Occurring Causes:
Hematogenous (originating from blood)
Traumatic (caused by injury)
Iatrogenic (caused by medical treatment)
Examples:
Arthroscopy
Arthrocentesis
Fracture repair
Common Infectious Agents:
Typically bacterial
Rarely viral, mycobacterial, or fungal
PATHOGENESIS
Initial Responses:
Synovitis and capsulitis (inflammation of the synovial membrane and capsule)
Fibrin deposition
Cellular infiltrates (migration of immune cells into tissues)
Enzymatic Activity:
Release of degradative enzymes such as collagenase, stromelysin, and metalloproteinases (MMP)
Cytokines involved: Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor (TNF)
This contributes to a cycle of cartilage matrix destruction
ACTIVATORS
Cells Involved:
Synoviocytes
Fibroblasts
Neutrophils
Macrophages
Key Factors:
Trauma and inflammation activate IL-1 and TNFα
Additional contributors include:
Metalloproteinases
Collagenase
Gelatinase
Stromelysin
Free radicals
Prostaglandins
Wear particles
Hyaluronate degradation
Impact on Articular Cartilage
Damage results from
Physical damage
Inflammatory mediators such as IL-1 and TNFα
Compromise in subchondral bone integrity and subsequent resorption
RISK FACTORS - FOALS
Factors similar to foal septicemia
Failure of Passive Transfer (FPT) increases risk of bacteremia leading to localized infection
Types of septic arthritis in foals include:
S-type
E-type
P-type
S-TYPE SEPSIS
Description:
Affects synovial membrane and fluid
Age Range:
Less than 1 week
Common Joints Involved:
Larger joints: stifle (knee) and tibiotarsal (hock)
Multiple joints are often affected
Clinical Signs:
Acute, severe lameness
Joint effusion (swelling due to fluid accumulation)
E-TYPE SEPSIS
Description:
Affects bone adjacent to articular cartilage and epiphysis
Age Range:
Weeks old
History:
Associated with FPT or other diseases such as pneumonia and diarrhea
Commonly Affected Joints:
Distal femur, talus, tibia, radius
Clinical Signs:
Mild lameness, possibly fever, followed by exacerbation with effusion
P-TYPE SEPSIS
Description:
Common in foals aged weeks to months
Often has a history of prior diseases
Common Sites Affected:
Distal physis of MCIII/MTIII (metacarpus/metatarsus), radius, tibia
Clinical Signs:
Initial lameness followed by a sudden acute severe lameness and swelling
Periarticular swelling usually without effusion
P-TYPE: DIAGNOSIS
Diagnostic Techniques:
Radiographs (X-rays)
Aspiration of physis (joint fluid extraction)
Possible bone biopsy
Critical Note:
Do NOT debride to avoid damaging the physis, which could lead to premature closure of growth plates
SEPTIC ARTHRITIS IN FOALS
Symptoms:
Presenting signs include lameness, joint effusion, potential fever
Diagnostic Procedures:
Radiographs
Synovial fluid analysis should show:
Cell count > 50,000 cells/mL
> 90% polymorphonuclear cells (PMNs)
Color may range from normal to cloudy, red, orange, or pink
Blood Work Findings:
Potential leukocytosis
Fibrinogen levels usually exceed 900 mg/dL when bone is involved
Ultrasound Findings:
Hypercellular fluid observed
FOALS: JOINT EVALUATION
Must identify all joints involved
U/S evaluation of umbilicus is critical
Prognosis:
Approximately 77% survival rate
RISK FACTORS - ADULTS
Iatrogenic Causes:
Risk associated with
Synovial surgeries
Fracture repairs
Arthrocentesis
Reported risk is 1 per 1279 injections (Aust Vet J 2013)
Staphylococcus spp. is most common (34.3% from retrospective of 206 cases, 2010)
Trauma:
Various causes can lead to infection
Enterobacteriaceae are more common after trauma, along with Staphylococcus, Pseudomonas, and fungi
Bacteremia is rare in adults
TRAUMA IN ADULTS
Key Note:
An open joint is an infected joint
SEPTIC ARTHRITIS IN ADULTS - CLINICAL SIGNS
Present similarly to foals
Key Symptoms:
Acute onset of severe lameness
Synovial effusion observed
Peri-articular heat and swelling
Potential fever
SEPTIC ARTHRITIS - DIAGNOSIS
Microbiology Techniques:
Gold Standard: Microbiology assessment
Gross Examination:
Evaluation of color, clarity, and viscosity of joint fluid
Clinicopathological Evaluation Includes:
Total protein
Cell count and differential
Staining of smears
DIAGNOSIS PROCEDURES
Cultural Techniques:
Culture and sensitivity tests should be performed early
Enrichment/blood culture media should be used for better yield
Fungal cultures should be submitted if needed
Repeat cultures if the initial sample comes back negative
In foals: aspirate the physis if physitis is suspected
DIAGNOSIS - CYTOLOGY
Fluid Color Assessments:
Normal = Pale yellow
Abnormal = Serosanguinous, orange, or turbid
Cell Count & Clarity:
Normal clarity = clear
Normal WBC < 500 cells/dL
Normal < 10% of neutrophils
Total Protein Assessment:
Normal total protein < 2.0 g/dL
SEPTIC ARTHRITIS - DIAGNOSIS
Most Common Isolate:
Staphylococcus spp. (34.3% from Equine Vet J 2010)
Must culture before initiating antibiotics
Technique Note: Tap away from the wound to avoid contamination
IMAGING TECHNIQUES
Imaging Modalities:
Radiographs:
Marked effusion
Associated soft tissue swelling
Osseous involvement if present
Ultrasound:
Assists in fluid aspiration and analysis
Hypercellular fluid assessment
For foals, check umbilicus
Nuclear Scintigraphy:
Applicable to fetlock joint and tarsocrural joint evaluation
TREATMENT
Critical Note:
To be successful, rapid disease recognition and immediate aggressive treatment are required
Therapeutic Innovations:
Intensive local therapies such as lavage, local antibiotics, and effective drainage
TREATMENT - GOALS
Objective is to
Return cartilage to a normal environment
Eradicate infection
Eliminate inflammation
Minimize matrix loss and cartilage damage
Consequences of Failure:
Irreversible structural damage
Decreased prognosis
Possible contralateral limb laminitis (inflammation of the hoof)
TREATMENT - AFTER SAMPLE ACQUISITION
Antibiotic Management:
Begin broad-spectrum antibiotics (e.g., Penicillin/Gentamicin) as foundational treatment
Lavage Technique:
Conduct lavage as early and often as possible
Use large volumes (5-10 liters) for optimal impact
TREATMENT - LAVAGE
Approach:
Arthroscopic techniques are best for rapid and accurate delivery
Aims to remove fibrin clots and perform targeted debridement
Needle lavage (through-and-through) for acute infections
Use large gauge needles (14, 16, 18g)
Place needles in all compartments of the joint
TREATMENT - LAVAGE UNDER ANESTHESIA
Sedation and Local Anesthesia
2% Mepivacaine may be used in joint
General anesthesia options include arthroscopy or arthrotomy
TREATMENT - LAVAGE SOLUTIONS
Recommended Solutions:
Balanced Electrolyte Solutions like Lactated Ringer's Solution
Prohibitions:
Do NOT add chlorhexidine or povidone-iodine due to tissue irritation and harm
Considerations:
+/- DMSO (Dimethyl sulfoxide) as an adjunct
TREATMENT - LAVAGE FREQUENCY
Conduct lavage every other day
Endpoint for Treatment:
Stop when lameness resolves, effusion and swelling normalize, and WBC levels in synovial fluid return to normal
TREATMENT - ANTIBIOTIC STRATEGY
General Approach:
Utilize broad-spectrum antibiotics initially, then switch to targeted therapy based on culture/sensitivity
Local Administration is Vital:
Encourages high local concentrations of antibiotics compared to systemic treatment
Duration of Antibiotics:
Minimum 2 weeks beyond resolution of clinical signs
TREATMENT - LOCAL ANTIBIOTICS
Administration Routes:
Intra-articular (IA), regional limb perfusion (RLP), intra-osseous (IO), or antibiotic-impregnated biomaterials
Continuous rate infusion (CRI) vs intermittent bolus administration
Targeted Approach:
Follow culture/sensitivity for specific pathogens
INTRA-ARTICULAR ADMINISTRATION OF ANTIBIOTICS
Technique Details:
Administer AFTER lavage is complete
Achieves high concentration of drug at the site (10-100x systemic levels)
500 mg Amikacin can maintain therapeutic levels for >72 hours for most common pathogens
Caution:
Avoid exceeding daily total systemic dose when treating multiple joints
REGIONAL LIMB PERFUSION
Procedure Steps:
Performed every other day (QOD)
Requires sedation and local anesthesia
Use of an Esmarch tourniquet (or pneumatic) for accessibility
Proper tourniquet placement is crucial
Inject slowly (over 5-10 minutes)
Keep tourniquet on for 30 minutes
Option for topical Surpass® application
REGIONAL LIMB PERFUSION - DOSAGE
Rule of Thumb:
Use 1/3 of systemic antibiotic dose
Dilute to 30 mL for the distal limb, or 60 mL for above carpus/tarsus
In CATTLE: Utilize RLP with Florfenicol for effective tissue concentrations against common pathogens
Caution:
Do NOT exceed total daily systemic dose
INTRA-OSSEOUS ANTIBIOTIC ADMINISTRATION
Technique Overview:
Requires sedation/local anesthesia
Drill a 4mm hole for access
Employ Esmarch tourniquet for the procedure
Inject antibiotics slowly
Leave the tourniquet in place for 30 minutes
ANALGESIA
Pain Management Considerations:
Patients experience excruciating pain, eventual contralateral limb laminitis may occur
Excessive time in recumbency can lead to further complications such as decubital ulcers, respiratory disease, gastrointestinal issues, and weight loss
ANALGESIA - STRATEGIES
Use of non-steroidal anti-inflammatory drugs (NSAIDs) requires monitoring for toxicity
Utilize GI protectants such as
Omeprazole AND Sucralfate
Options includes opiates and continuous rate infusion (CRI) of
Lidocaine, Ketamine, and hind limb epidural catheters for enhanced analgesia
RESPONSE TO TREATMENT
Clinical Assessment:
Clinical lameness is the most reliable measure for response to treatment
Caution: NSAIDs and analgesics may mask pain, leading to false impressions of treatment success
Recommendation:
Do not discontinue any antibiotics or lavage until a full evaluation post-analgesics is conducted
ADJUNCT TREATMENT
Treatment Goals:
Aim to
Eradicate infection
Eliminate inflammation
Return cartilage to its normal environment
Options include intra-articular administration of Hyaluronic Acid (HA), Autologous Conditioned Serum (ACS), or Platelet-Rich Plasma (PRP)
Hyaluronic Acid (HA) is considered the most plausible option for effective recovery